ATE538107T1 - Isoxazol-derivate zur anwendung als cyclooxygenase-inhibitoren - Google Patents

Isoxazol-derivate zur anwendung als cyclooxygenase-inhibitoren

Info

Publication number
ATE538107T1
ATE538107T1 AT10005150T AT10005150T ATE538107T1 AT E538107 T1 ATE538107 T1 AT E538107T1 AT 10005150 T AT10005150 T AT 10005150T AT 10005150 T AT10005150 T AT 10005150T AT E538107 T1 ATE538107 T1 AT E538107T1
Authority
AT
Austria
Prior art keywords
cyclooxygenase inhibitors
isoxazole derivatives
cyclooxygenase
inhibitors
cox
Prior art date
Application number
AT10005150T
Other languages
English (en)
Inventor
Antonio Scilimati
Nunno Leonardo Di
Paola Vitale
Paola Patrignani
Stefania Tacconelli
Ettore Porreca
Liborio Stuppia
Original Assignee
Univ Bari
Uni Degli Studi Di Chieti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bari, Uni Degli Studi Di Chieti filed Critical Univ Bari
Application granted granted Critical
Publication of ATE538107T1 publication Critical patent/ATE538107T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT10005150T 2004-01-12 2005-01-12 Isoxazol-derivate zur anwendung als cyclooxygenase-inhibitoren ATE538107T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000019A ITMI20040019A1 (it) 2004-01-12 2004-01-12 Derivati isossazolici e loro impiego come inibitori della ciclossigenasi

Publications (1)

Publication Number Publication Date
ATE538107T1 true ATE538107T1 (de) 2012-01-15

Family

ID=34779432

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05702217T ATE468329T1 (de) 2004-01-12 2005-01-12 Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren
AT10005150T ATE538107T1 (de) 2004-01-12 2005-01-12 Isoxazol-derivate zur anwendung als cyclooxygenase-inhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05702217T ATE468329T1 (de) 2004-01-12 2005-01-12 Isoxazolderivate und deren verwendung als cyclooxygenaseinhibitoren

Country Status (7)

Country Link
EP (2) EP1706390B1 (de)
AT (2) ATE468329T1 (de)
DE (1) DE602005021309D1 (de)
DK (1) DK1706390T3 (de)
ES (1) ES2344738T3 (de)
IT (1) ITMI20040019A1 (de)
WO (1) WO2005068442A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943588B2 (en) 2006-03-28 2011-05-17 Trustees Of Dartmouth College Method for preventing or treating neuropathic pain
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1128526A (en) * 1979-10-05 1982-07-27 Cdc Life Sciences Inc. 3,4-diarylisoxazol-5-acetic acids
JPH04134077A (ja) * 1990-09-21 1992-05-07 Taiho Yakuhin Kogyo Kk イソオキサゾール化合物
EP0633254A1 (de) * 1991-05-01 1995-01-11 Taiho Pharmaceutical Co., Ltd. Neue isoxazolderivate und ihre salze
ATE223390T1 (de) * 1995-02-13 2002-09-15 Searle & Co Substituierte isoxazole zur behandlung von entzündung
EP0979226B1 (de) * 1997-04-21 2005-11-09 Sumitomo Pharmaceuticals Company, Limited Isoxazolderivate
AU2001253749A1 (en) * 2000-04-25 2001-11-07 Pharmacia Corporation 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6673818B2 (en) * 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
RU2284324C2 (ru) * 2001-10-02 2006-09-27 Фармация Корпорейшн Способ получения бензолсульфонилов
AU2002337843A1 (en) * 2001-10-12 2003-04-22 Onconova Therapeutics, Inc. Processes for the preparation of substituted isoxazoles and 2-isoxazolines
AU2003220180A1 (en) * 2002-03-15 2003-09-29 Pharmacia Corporation Crystalline parecoxib sodium
WO2003087062A2 (en) * 2002-04-05 2003-10-23 Cadila Healthcare Limited 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
DE10237883A1 (de) * 2002-08-19 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
US20060058363A1 (en) * 2002-10-22 2006-03-16 Zhaoyin Wang Nitric oxide releasing selective cyclooxygenase-2 inhibitors
HUP0302219A2 (hu) * 2003-07-16 2005-03-29 Richter Gedeon Vegyészeti Gyár Rt. N-hidroxi-4-(3-fenil-5-metil-izoxazol-4-il)-benzolszulfonamid-szolvátok, eljárás előállításukra és alkalmazásuk

Also Published As

Publication number Publication date
ATE468329T1 (de) 2010-06-15
DK1706390T3 (da) 2010-08-23
WO2005068442A3 (en) 2006-04-06
DE602005021309D1 (de) 2010-07-01
EP1706390B1 (de) 2010-05-19
ITMI20040019A1 (it) 2004-04-12
ES2344738T3 (es) 2010-09-06
EP2246337B1 (de) 2011-12-21
WO2005068442A2 (en) 2005-07-28
EP2246337A1 (de) 2010-11-03
EP1706390A2 (de) 2006-10-04

Similar Documents

Publication Publication Date Title
CL2007002684A1 (es) Combinacion que comprende un antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina; composicion farmaceutica que la comprende; kit farmaceutico; y uso para tratar perjuicio cognitivo y/o trastorno psicoticos.
BRPI0720625A2 (pt) Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
NO20053215D0 (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
ATE451364T1 (de) Als modulatoren des dopamin-d3-rezeptors geeignete azabicycloä3.1.0ühexanderivate
PT2061814E (pt) Anticorpos e imunoconjugados e suas utilizações
DE60327443D1 (de) Neue oxazolverbindungen als inhibitoren des transforming growth factor (tgf)
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
CR10611A (es) Isoxazolinas insecticidas
ES2422556T3 (es) Tratamiento de hepatitis vírica
AT9566U3 (de) Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
DE602005027307D1 (de) Arylanilinderivate als agonisten des beta2-adrenergen rezeptors
GT200600359A (es) Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
AR059444A1 (es) Composiciones ramnolipidicas y metodos de uso relacionados
AR059445A1 (es) Composiciones de antimicoticos ramnolipidicos y metodos de uso relacionados
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
BRPI0617479A2 (pt) método e composição útil para manter ou melhorar a saúde gastrintestiinal de um animal, kit, meio para comunicação de informações ou instruções, e, uso de uma composição
CY2015007I1 (el) Ενωσεις, συνθεσεις και χρησεις παραγωγων βενζοθειαζολης
DE502004004192D1 (de) Drehknopf eines bediengerätes
CL2007002388A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas.
EA200601568A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
DE602005014646D1 (de) Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase
CL2008002058A1 (es) Metodo para la preparacion de trifluoralquil-fenil-sulfonamidas y de sulfonamidas heterociclicas usando n-trifluoroacteilmorfolina; su metodo de preparacion y su uso.